BUY, SELL, HOLD (2)

Options Bulls Brush Off Johnson & Johnson's Lowered Outlook

A stronger U.S. dollar is weighing on international sales

Digital Content Manager
Jul 19, 2022 at 10:05 AM
facebook X logo linkedin


Johnson & Johnson (NYSE:JNJ) took over the earnings confessional earlier to report a second-quarter earnings and revenue beat, thanks in part to the double-digit sales growth of cancer drug Darzalex and Crohn's disease drug Stelara. However, the company slashed its full-year adjusted profit outlook, noting a stronger U.S. dollar is weighing on international sales. At last check, JNJ is up 0.4% at $174.96.

The equity took a step back after hitting an April 25, record high of $186.69, but bounced off the $167 region in mid-June -- its lowest level since March -- to reclaim support from its 180-day moving average. Over the past nine months, Johnson & Johnson stock has added 8.8%.

At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), JNJ's 50-day put/call volume ratio of 1.01 sits higher than 93% of readings from the past 12 months. This means long puts have been getting picked up at a much faster-than-usual pace in the last 10 weeks.

Today's options are more optimistic. So far, 5,969 calls and 2,991 puts have crossed the tape, or triple the intraday average. The most popular contracts are the 7/22 182.50- and 180-strike calls.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.